The brand Magtein by Threotech has a sales value of approximately US $438 million
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
The EU approval of DAWNZERA is an important milestone that reflects our ongoing commitment to bring this innovative medicine to people in need across the globe
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
The partnership also sets the stage for broader collaboration on rare disease treatments
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Under the terms of the deal, AstraZeneca gains exclusive rights to JAB-23E73 outside of mainland China
The portfolio includes foundational patents on the production, composition, and commercial use of NR
Subscribe To Our Newsletter & Stay Updated
